23 programming-"https:"-"Inserm"-"FEMTO-ST" "https:" "https:" "https:" "https:" "https:" "Dr" "UCL" Postdoctoral positions at University of London in United Kingdom
Sort by
Refine Your Search
-
:38183983) using cutting-edge genomics technologies (https://www.biorxiv.org/content/10.1101/2024.12.20.629444v5) to provide core knowledge for development of new therapies and management strategies for PPK
-
for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and the Francis Crick
-
About the Role Dr. Benjamin Werner from Barts Cancer Institute in London is seeking a post doc candidate to join his team at Queen Mary University of London to work on the evolutionary dynamics
-
. The Institute is organised into six separate research centres which, though complementary and following the Institute strategic plan, also have Centre-specific objectives and requirements About Queen Mary
-
international networks, close links to museums and heritage organisations, and an active programme of seminars, workshops, and public events. The post will also require significant amount of time spent
-
About the role This role supports a multidisciplinary programme investigating the role of the Maresins, a family of pro-resolving lipid mediators, in early cancer development. You will process
-
months. The position is funded by Dr Gustav Mogull’s Royal Society University Research Fellowship, “Gravitational Waves from Worldline Quantum Field Theory”. Applicants should have a strong research record
-
the Centre for Experimental Cancer Medicine and the Barts NHS Trust to achieve improvements in cancer patient care. BCI is also a partner in the CRUK City of London Major Centre (together with UCL, Kings and
-
three-year full-time position funded by the EPSRC project INDIMO: Invariant Discovery and Monitoring for Message-Passing Programs, starting around March 2026 (flexible start date). The successful
-
research project led by Dr Gemma Brierley, whose group investigates the molecular underpinnings of insulin resistance. This project builds on our previous work using agonistic antibodies to activate mutated